论文部分内容阅读
2013年3月13日,上海—微创心脉医疗科技(上海)有限公司(以下简称“微创心脉”)位于上海国际医学园区的办公、研发、生产大楼正式启用。上海微创医疗器械(集团)有限公司总裁张燕女士、首席技术官罗七一先生、首席营销官彭博先生、供应链资深副总裁潘孔荣先生等集团领导莅临心脉公司,出席了剪彩仪式。微创心脉产品有:Aegis-B分叉型支架系统为国内唯一用于治疗腹主动脉瘤的一体式支架系统,可实现量
March 13, 2013, Shanghai - The office, research and development and manufacturing building of Shanghai Minimally Invited Heart Medical Technology (Shanghai) Co., Ltd. (hereinafter referred to as “Minimally Invasive Heart Service”) was officially opened in Shanghai International Medical Park. Ms. Zhang Yan, President of Shanghai Minimally Invasive Medical Devices (Group) Co., Ltd., Mr. Luo Qiyi, Chief Technology Officer, Mr. Peng Bo, Chief Marketing Officer, Mr. Pan Kongrong, Senior Vice President of Supply Chain and other group leaders visited the heart ribbon company and attended the ribbon-cutting ceremony. Minimally invasive heart products include: Aegis-B bifurcated stent system is the only one for the treatment of abdominal aortic aneurysm stent system, the amount can be achieved